The catalytic subunit of glutamate-cysteine ligase, Gclc, has been reported to ameliorate accumulated glutamate in the absence of cystine, mitigating ferroptosis in tumor cells [33] (Fig. 7a). Here, GCLC is linked to neoplasm.